Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Pediatr Dermatol ; 40(1): 107-112, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36262015

RESUMO

BACKGROUND: Autosomal recessive congenital ichthyosis (ARCI) is a heterogenous group of rare keratinization disorders. To date, more than 13 causative genes have been identified. However, data on clinical and molecular characteristics including genotype-phenotype correlation are lacking in Thailand. OBJECTIVE: We collected cases diagnosed with non-syndromic ARCI and syndromic recessive congenital ichthyosis at the Institute of Dermatology from 2011 to 2021 and performed genetic testing with next-generation sequencing and assessed clinical details. METHODS: Baseline demographic data, birth history, family history, skin manifestations at birth, current cutaneous manifestations, comorbidities, and response to treatments were assessed. DNA was screened for mutations using targeted gene sequencing of 45 genes related to congenital ichthyosis. RESULTS: A total of 33 patients were analyzed with an average age of 23.8 ± 13.9 years. Congenital ichthyosiform erythroderma (CIE) was most common (60.6%), followed by lamellar ichthyosis (18.2%), self-improving congenital ichthyosis (6.1%), Netherton syndrome (6.1%), ichthyosis prematurity syndrome (3%), Sjögren-Larsson syndrome (3%) and bathing suit ichthyosis (3%). Eight genes were found with pathogenic variants in our cohort as follows: ABCA12 42.4% (14/33), NIPAL4 24.2% (8/33), TGM1 15.2% (5/33), SPINK5 6.1% (2/33), ALDH3A2 3% (1/33), SLC27A4 3% (1/33), CYP4F22 3% (1/33), and ST14 3% (1/33). Clinically, 79% of patients with ABCA12 pathogenic variants in this study had CIE, 79% of w had novel biallelic pathogenic compound heterozygous variants, whereas 21% had homozygous missense variants. CONCLUSIONS: This is the first study to describe clinical and molecular findings of ARCI in a cohort from Thailand. Our findings demonstrate the clinical spectrum of the diseases and expand the molecular findings in a Southeast Asian population.


Assuntos
Eritrodermia Ictiosiforme Congênita , Ictiose Lamelar , Ictiose , Humanos , Genes Recessivos , Eritrodermia Ictiosiforme Congênita/diagnóstico , Eritrodermia Ictiosiforme Congênita/epidemiologia , Eritrodermia Ictiosiforme Congênita/genética , Ictiose/genética , Ictiose Lamelar/diagnóstico , Ictiose Lamelar/epidemiologia , Ictiose Lamelar/genética , Mutação , Tailândia/epidemiologia , Criança , Adolescente , Adulto Jovem , Adulto
3.
J Invest Dermatol ; 140(3): 624-635.e7, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31493396

RESUMO

Dermatofibromas are common benign skin lesions, the etiology of which is poorly understood. We identified two unrelated pedigrees in which there was autosomal dominant transmission of multiple dermatofibromas. Whole exome sequencing revealed a rare shared heterozygous missense variant in the F13A1 gene encoding factor XIII subunit A (FXIII-A), a transglutaminase involved in hemostasis, wound healing, tumor growth, and apoptosis. The variant (p.Lys679Met) has an allele frequency of 0.0002 and is predicted to be a damaging mutation. Recombinant human Lys679Met FXIII-A demonstrated reduced fibrin crosslinking activity in vitro. Of note, the treatment of fibroblasts with media containing Lys679Met FXIII-A led to enhanced adhesion, proliferation, and type I collagen synthesis. Immunostaining revealed co-localization between FXIII-A and α4ß1 integrins, more prominently for Lys679Met FXIII-A than the wild type. In addition, both the α4ß1 inhibitors and the mutation of the FXIII-A Isoleucine-Leucine-Aspartate-Threonine (ILDT) motif prevented Lys679Met FXIII-A-dependent proliferation and collagen synthesis of fibroblasts. Our data suggest that the Lys679Met mutation may lead to a conformational change in the FXIII-A protein that enhances α4-integrin binding and provides insight into an unexpected role for FXIII-A in the pathobiology of familial dermatofibroma.


Assuntos
Fator XIII/genética , Fibrina/metabolismo , Histiocitoma Fibroso Benigno/genética , Padrões de Herança , Pele/patologia , Domínio Catalítico/genética , Proliferação de Células/genética , Colágeno Tipo I/biossíntese , Análise Mutacional de DNA , Fator XIII/metabolismo , Feminino , Fibroblastos , Células HEK293 , Histiocitoma Fibroso Benigno/patologia , Humanos , Integrina alfa4/metabolismo , Masculino , Mutagênese Sítio-Dirigida , Mutação de Sentido Incorreto , Linhagem , Conformação Proteica em alfa-Hélice/genética , Conformação Proteica em Folha beta/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Pele/citologia , Relação Estrutura-Atividade , Sequenciamento do Exoma
4.
Am J Trop Med Hyg ; 96(5): 1160-1163, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28138050

RESUMO

AbstractSeveral case reports of autochthonous leishmaniasis in Thailand have been published since 1996. Most of the previous cases presented with visceral leishmaniasis (VL) and were mostly reported in southern part of Thailand. Recently, it has been evident that Leishmania martiniquensis is the main cause of Leishmania infection in Thailand. However, Leishmania siamensis (PCM2 Trang isolate) was found to be of a separate lineage with restricted distribution in southern Thailand and also a cause of disseminated dermal and visceral leishmaniasis in one published case. Here we report the first patient from central Thailand with human immunodeficiency virus infection presenting with disseminated dermal leishmaniasis. Polymerase chain reaction and DNA sequencing analysis (large subunit of RNA polymerase II and 18S ribosomal RNA internal transcribed spacer 1) from the tissue biopsy sample revealed the pathogen sequences to be highly homologous to PCM2 Trang strain previously reported from southern Thailand.


Assuntos
Antiprotozoários/uso terapêutico , Antivirais/uso terapêutico , Derme/patologia , Infecções por HIV/virologia , Leishmaniose Tegumentar Difusa/parasitologia , Adulto , Anfotericina B/uso terapêutico , Coinfecção , DNA Espaçador Ribossômico/genética , Derme/efeitos dos fármacos , Derme/parasitologia , Derme/virologia , Feminino , HIV/efeitos dos fármacos , HIV/crescimento & desenvolvimento , Infecções por HIV/diagnóstico , Infecções por HIV/tratamento farmacológico , Infecções por HIV/patologia , Humanos , Itraconazol/uso terapêutico , Leishmania/efeitos dos fármacos , Leishmania/genética , Leishmania/isolamento & purificação , Leishmaniose Tegumentar Difusa/diagnóstico , Leishmaniose Tegumentar Difusa/tratamento farmacológico , Leishmaniose Tegumentar Difusa/patologia , Proteínas de Protozoários/genética , RNA Polimerase II/genética , Análise de Sequência de DNA , Tailândia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA